1 Min Read
* ISR HOLDING STARTS A NEW SUBSIDIARY - ISR ONCOLOGY AB
* 25 DECIDED TO FORM A SUBSIDIARY WITH A FOCUS ON CANCER TREATMENT. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.